SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Dinu Raluca

(Last) (First) (Middle)
C/O GIGPEAK, INC.
130 BAYTECH DRIVE

(Street)
SAN JOSE CA 95134

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GigPeak, Inc. [ GIG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
05/03/2016
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/03/2016 M 2,500(1) A $0.00 45,814 D
Common Stock 05/03/2016 F 992(2) D $2.35(3) 44,822 D
Common Stock 05/03/2016 M 54,087(4) A $0.00 98,909 D
Common Stock 05/03/2016 F 21,446(5) D $2.35(3) 77,463 D
Common Stock 05/03/2016 M 12,500(6) A $0.00 89,963 D
Common Stock 05/03/2016 F 4,957(7) D $2.35(3) 85,006 D
Common Stock 05/03/2016 M 710(8) A $0.00 85,716 D
Common Stock 05/03/2016 F 282(9) D $2.35(3) 85,434 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (RSUs) $0.00 05/03/2016 M 2,500(1) (10) (10) Common Stock 2,500 $0.00 20,000 D
Restricted Stock Units (RSUs) $0.00 05/03/2016 M 54,087(4) (11) (11) Common Stock 54,087 $0.00 162,259 D
Restricted Stock Units (RSUs) $0.00 05/03/2016 M 11,500(6) (12) (12) Common Stock 11,500 $0.00 76,000 D
Restricted Stock Units (RSUs) $0.00 05/03/2016 M 710(8) (13) (13) Common Stock 710 $0.00 1,420 D
Explanation of Responses:
1. 2,500 Restricted Stock Units ("RSUs") issued in the grant to Dr. Dinu on 2/10/2014 vested on 5/1/2016 according to the vesting schedule previously reported.
2. 992 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
3. The closing price of the Company's common stock on 5/2/2016.
4. 54,087 RSUs issued in the grant to Dr. Dinu on 3/26/2015 vested on 5/1/2016 according to the vesting schedule previously reported.
5. 21,446 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
6. 12,500 RSUs issued in the grant to Dr. Dinu on 11/19/2015 vested on 5/1/2016 according to the vesting schedule previously reported.
7. 4,957 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
8. 710 RSUs issued in the grant to Dr. Dinu on 1/5/2016 vested on 5/1/2016 according to the vesting schedule previously reported.
9. 282 shares of Common Stock were withheld by the Company for the purposes of satisfying tax withholding obligations in connection with such vesting as previously reported by the Company.
10. The RSUs vest as follows: 25% vested on May 1, 2015. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2015 and ending on May 1, 2018, as previously reported.
11. The RSUs vest as follows: 25% vested on May 1, 2016. The remaining 75% vest in twelve quarterly installments thereafter, beginning on August 1, 2016 and ending on May 1, 2019, as previously reported.
12. The RSUs vest in eight quarterly installments beginning on February 1, 2016 and ending on November 1, 2017, as previously reported.
13. The RSUs vest in four quarterly installments beginning on February 1, 2016 and ending on November 1, 2016, as previously reported.
Remarks:
The vesting date of the RSUs was May 1, 2016, as previously reported by the Issuer, which fell on a Sunday this year. Normally the shares will issue on the same date as the vesting date, as reported in the previously filed Form 4s for vesting of RSUs. However, when the vesting date falls on a weekend or federal holiday, due to the normal processing required by the Issuer's transfer agent, it can take up to two business days after the first business day following the vesting date for the resulting shares to be issued. Therefore the shares resulting from the vesting on May 1, 2016 were not issued until May 3, 2016, as reported in this Form 4.
/s/ Dr. Raluca Dinu 05/05/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.